A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Triple-negative Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Jiong Wu)Contact: Principal Investigator (Jiong Wu)Contact: Principal Investigator (Jian Zhang)
Study leads
Jiong Wu
Principal Investigator
Fudan University
Jian Zhang
Principal Investigator
Fudan University